Eiry Roberts's Net Worth

$14.1 Million

Estimate Recalculated Apr 17, 2024 04:21PM EST

Who is Eiry Roberts?

Eiry Roberts has an estimated net worth of $14.1 Million. This is based on reported shares across multiple companies, which include NEUROCRINE BIOSCIENCES INC, and AMICUS THERAPEUTICS, INC..

SEC CIK

Eiry Roberts's CIK is 0001727606

Past Insider Trading and Trends

2023 was Eiry Roberts's most active year for acquiring shares with 13 total transactions. Eiry Roberts's most active month to acquire stocks was the month of January. 2023 was Eiry Roberts's most active year for disposing of shares, totalling 25 transactions. Eiry Roberts's most active month to dispose stocks was the month of November. 2023 saw Eiry Roberts paying a total of $7,882,349.40 for 200,043 shares, this is the most they've acquired in one year. In 2023 Eiry Roberts cashed out on 235,580 shares for a total of $23,607,126.75, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

NEUROCRINE BIOSCIENCES INC (NBIX) Snapshot price: $136.5

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-4.49%
-1.11K
$132.96
-$148,121.78
23.72K
Scheduled
Feb 13
Form 4
-4.50%
-2.10K
$138.23
-$290,968.09
44.55K
Scheduled
Feb 6 - Feb 8
Form 4
-6.54%
-1.46K
$140.79
-$205,131.90
20.83K
Scheduled
Jan 31
Form 4
-33.87%
-10.00K
$126.74
-$1,267,448.00
19.52K
Scheduled
Dec 22
Form 4
—
0
$100.68
-$546,618.81
29.52K
Scheduled
Dec 12
Form 4
—
0
$99.45
-$3,249,914.84
29.52K
Scheduled
Dec 7 - Dec 8
Form 4
—
0
$98.92
-$354,487.52
29.52K
Scheduled
Dec 6
Form 4
-9.77%
-3.20K
$107.38
-$343,387.81
29.52K
Aug 21
Form 4
-35.08%
-14.40K
$103.48
-$1,490,058.72
26.64K
Apr 24
Form 4/A
—
0
—
—
0
Form 4
—
0
—
—
0
Feb 13
Form 4
-10.77%
-16.52K
$103.68
-$1,697,706.71
136.96K
Scheduled
Feb 6 - Feb 8
Form 4
-5.27%
-1.46K
$109.99
-$160,253.54
26.17K
Scheduled
Jan 31
Form 4
-4.98%
-3.72K
$80.36
-$299,590.39
71.11K
Scheduled
Feb 7 - Feb 8
Form 4
—
0
—
—
0
Jan 31
Form 4
-11.01%
-2.63K
$74.50
-$196,087.68
21.28K
Scheduled
Jan 10
Form 4/A
—
0
—
—
0
Feb 8
Form 4
-6.17%
-2.36K
$116.75
-$275,943.91
35.92K
Scheduled
Feb 8
Form 4
-14.24%
-2.63K
$111.06
-$292,297.29
15.85K
Scheduled
Jan 8
Form 4
-14.34%
-2.26K
$90.74
-$204,809.89
13.48K
Scheduled
Nov 12
Form 4
-16.47%
-2.26K
$118.84
-$268,225.27
11.45K
Scheduled
Aug 5
Form 4
—
0
$103.91
-$260,950.00
9.42K
Scheduled
Jun 23
Form 4
-17.04%
-1.93K
$99.47
-$192,376.33
9.42K
Scheduled
Apr 24
Form 4
-17.88%
-1.62K
$103.31
-$167,675.38
7.45K
Scheduled
Feb 7
Form 4
—
0
—
—
0
Feb 6
Form 4
-30.52%
-2.63K
$111.11
-$292,444.94
5.99K
Scheduled
Jan 8
Form 4
—
0
—
—
0
Feb 7
Form 4
-37.14%
-1.86K
$84.09
-$156,158.66
3.14K
Scheduled
Jan 8
Form 4
—
0
—
—
0
Feb 5
Form 4
—
0
—
—
0
Jan 8
Form 3
—
0
—
—
0
No matching records found

AMICUS THERAPEUTICS, INC. (FOLD) Snapshot price: $13

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+24.23%
8.58K
—
—
44.01K
Jun 8
Form 4
+55.67%
12.67K
—
—
35.43K
Jun 9
Form 4
∞
22.76K
—
—
22.76K
Jun 10
Form 3
—
0
—
—
0
No matching records found